228 related articles for article (PubMed ID: 10636070)
1. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Ohlsson B; Fredäng N; Axelson J
Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
[TBL] [Abstract][Full Text] [Related]
2. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
4. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
5. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
[TBL] [Abstract][Full Text] [Related]
7. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
[TBL] [Abstract][Full Text] [Related]
8. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
Terashima H; Debas HT; Bunnett NW
Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
13. Identification of gastrin as a growth peptide in human pancreatic cancer.
Smith JP; Fantaskey AP; Liu G; Zagon IS
Am J Physiol; 1995 Jan; 268(1 Pt 2):R135-41. PubMed ID: 7840313
[TBL] [Abstract][Full Text] [Related]
14. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
Smith AJ; McKernan RM
Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
[TBL] [Abstract][Full Text] [Related]
15. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718.
Thumwood CM; Hong J; Baldwin GS
Exp Cell Res; 1991 Jan; 192(1):189-92. PubMed ID: 1984410
[TBL] [Abstract][Full Text] [Related]
17. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
[TBL] [Abstract][Full Text] [Related]
18. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Jang JY; Kim SW; Ku JL; Park YH; Park JG
World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
20. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
Sandvik AK; Waldum HL
Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
